Duminda Bandara Basnayake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Duminda Bandara Basnayake has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Thamara Kannangara
Department of Surgery, University of Peradeniya & Teaching Hospital Peradeniya, Kandy 2017, Sri Lanka
4 shared publications - Abdul Wahid Mohomad Wazil
Department of Nephrology and Renal Transplant, Teaching Hospital Kandy, Kandy, Sri Lanka
3 shared publications - Nishantha Nanayakkara
Nephrology and Kidney Transplant Unit, National Hospital, Kandy, Sri Lanka
2 shared publications - R. M. B. S. S. Mahanama
Department of Nephrology and Renal Transplant, Teaching Hospital Kandy, Kandy, Sri Lanka
2 shared publications - A. M. Ameer
Department of Medicine, Teaching Hospital Kandy, Kandy, Sri Lanka
1 shared publication - Aisha Lateef
Department of Medicine, Woodlands Health, Singapore
1 shared publication
Latest Publications
- Open Access
- 18 September 2024
- Published by BMJ in Lupus Science & Medicine
- Vol. 11 (2) , e001217
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus
Objectives The lupus low disease activity state (LLDAS) allows for certain clinical and/or serological activity of SLE, provided overall disease activity does not exceed predefined cut-offs. This study aimed to evaluate the outcomes of patients who achieved LLDAS with clinical activity, serological activity only or neither clinical nor serological activity. Methods Patients with SLE enrolled in a prospective multinational cohort from March 2013 to December 2020 who were in LLDAS at least once were included. Visits that fulfilled both LLDAS and Definition of Remission in SLE (DORIS) criteria were excluded. Results 2099 patients were included, with median follow-up of 3.5 (IQR 1.3–5.8) years. At 6150 visits, patients were in LLDAS but not DORIS criteria; of these 1280 (20.8%) had some clinical activity, 3102 (50.4%) visits had serological activity only and 1768 (28.8%) visits had neither clinical nor serological activity. Multivariable regression analysis showed that compared with non-LLDAS, all three subsets of LLDAS had a protective association with flares in the ensuing 6 months and damage accrual in the ensuing 36 months. LLDAS with no clinical or serological activity had a significantly stronger protective association with severe flares in the ensuing 6 months compared with LLDAS with clinical activity (HR 0.47, 95% CI (0.27 to 0.82), p=0.007). Conclusions LLDAS without any clinical activity accounted for almost 80% of LLDAS visits. This study confirms that all subsets of LLDAS are associated with reduced flare and damage accrual. However, LLDAS without any clinical or serological activity has the strongest protective association with severe flares.
- 18 September 2024
- Published by BMJ in Lupus Science & Medicine
- Vol. 11 (2) , e001217
Open AccessCharacterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus
Objectives The lupus low disease activity state (LLDAS) allows for certain clinical and/or serological activity of SLE, provided overall disease activity does not exceed predefined cut-offs. This study aimed to evaluate the outcomes of patients who achieved LLDAS with clinical activity, serological activity only or neither clinical nor serological activity. Methods Patients with SLE enrolled in a prospective multinational cohort from March 2013 to December 2020 who were in LLDAS at least once were included. Visits that fulfilled both LLDAS and Definition of Remission in SLE (DORIS) criteria were excluded. Results 2099 patients were included, with median follow-up of 3.5 (IQR 1.3–5.8) years. At 6150 visits, patients were in LLDAS but not DORIS criteria; of these 1280 (20.8%) had some clinical activity, 3102 (50.4%) visits had serological activity only and 1768 (28.8%) visits had neither clinical nor serological activity. Multivariable regression analysis showed that compared with non-LLDAS, all three subsets of LLDAS had a protective association with flares in the ensuing 6 months and damage accrual in the ensuing 36 months. LLDAS with no clinical or serological activity had a significantly stronger protective association with severe flares in the ensuing 6 months compared with LLDAS with clinical activity (HR 0.47, 95% CI (0.27 to 0.82), p=0.007). Conclusions LLDAS without any clinical activity accounted for almost 80% of LLDAS visits. This study confirms that all subsets of LLDAS are associated with reduced flare and damage accrual. However, LLDAS without any clinical or serological activity has the strongest protective association with severe flares.
- Open Access
- 13 January 2020
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 14 (1) , 1-5
Atypical hemolytic uremic syndrome: a case report
Background: Thrombotic microangiopathy is a pathological condition comprised of microvascular thrombosis involving any organ of the body leading to thrombocytopenia, Coombs-negative hemolytic anemia, and end-organ damage. The most common forms of thrombotic microangiopathies are Shiga toxin-producing Escherichia coli-mediated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome. The atypical hemolytic uremic syndrome occurs due to genetic and acquired mutations in complement regulatory factors and to complement activation factors in the immune system, mainly the alternative pathway. Clinical manifestations and outcomes differ with the prevalent mutations of the patient. Currently, available treatment modalities are therapeutic plasma exchange and a monoclonal antibody against C5, eculizumab. We report a case of a Sri Lankan girl diagnosed with atypical hemolytic uremic syndrome complicated with septicemia, hemolytic anemia, acute kidney injury, pulmonary hemorrhage with respiratory failure, and hypertension who had a complete remission following long-term (30 months) therapeutic plasma exchange. Case presentation: A 15-year-old Sri Lankan girl was transferred from a local hospital with the features of septicemia and acute kidney injury for specialized management. She had high blood pressure (180/100 mmHg) on admission. She underwent appendicectomy based on suspicion of acute appendicitis as the cause of sepsis. Following surgery, her condition deteriorated, and intensive care unit management was warranted because she developed pulmonary hemorrhages and respiratory failure requiring mechanical ventilation and renal replacement therapy in the form of hemodialysis. Her blood investigations showed microangiopathic hemolytic anemia, thrombocytopenia, elevated lactate dehydrogenase, and reduced human complement C3 levels, together with a normal coagulation profile. She was diagnosed with atypical hemolytic uremic syndrome and was initiated on therapeutic plasma exchange and other supportive therapy, including corticosteroids. Following a lengthy course of plasma exchange, complete recovery was achieved. Conclusion: The atypical hemolytic uremic syndrome is a rare disease entity requiring a high index of suspicion to diagnose. It is a diagnosis of exclusion. Early diagnosis with prompt treatment will render a better outcome. The atypical hemolytic uremic syndrome needs to be considered in all patients with thrombotic microangiopathy.
- 13 January 2020
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 14 (1) , 1-5
Open AccessAtypical hemolytic uremic syndrome: a case report
Background: Thrombotic microangiopathy is a pathological condition comprised of microvascular thrombosis involving any organ of the body leading to thrombocytopenia, Coombs-negative hemolytic anemia, and end-organ damage. The most common forms of thrombotic microangiopathies are Shiga toxin-producing Escherichia coli-mediated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome. The atypical hemolytic uremic syndrome occurs due to genetic and acquired mutations in complement regulatory factors and to complement activation factors in the immune system, mainly the alternative pathway. Clinical manifestations and outcomes differ with the prevalent mutations of the patient. Currently, available treatment modalities are therapeutic plasma exchange and a monoclonal antibody against C5, eculizumab. We report a case of a Sri Lankan girl diagnosed with atypical hemolytic uremic syndrome complicated with septicemia, hemolytic anemia, acute kidney injury, pulmonary hemorrhage with respiratory failure, and hypertension who had a complete remission following long-term (30 months) therapeutic plasma exchange. Case presentation: A 15-year-old Sri Lankan girl was transferred from a local hospital with the features of septicemia and acute kidney injury for specialized management. She had high blood pressure (180/100 mmHg) on admission. She underwent appendicectomy based on suspicion of acute appendicitis as the cause of sepsis. Following surgery, her condition deteriorated, and intensive care unit management was warranted because she developed pulmonary hemorrhages and respiratory failure requiring mechanical ventilation and renal replacement therapy in the form of hemodialysis. Her blood investigations showed microangiopathic hemolytic anemia, thrombocytopenia, elevated lactate dehydrogenase, and reduced human complement C3 levels, together with a normal coagulation profile. She was diagnosed with atypical hemolytic uremic syndrome and was initiated on therapeutic plasma exchange and other supportive therapy, including corticosteroids. Following a lengthy course of plasma exchange, complete recovery was achieved. Conclusion: The atypical hemolytic uremic syndrome is a rare disease entity requiring a high index of suspicion to diagnose. It is a diagnosis of exclusion. Early diagnosis with prompt treatment will render a better outcome. The atypical hemolytic uremic syndrome needs to be considered in all patients with thrombotic microangiopathy.
- Open Access
- 3 July 2019
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 13 (1) , 1-4
Ethylene glycol intoxication following brake fluid ingestion complicated with unilateral facial nerve palsy: a case report
Brake oil is an automobile transmission fluid composed of a mixture of toxic alcohols such as ethylene glycols and glycol ethers. Both accidental and intentional ingestion cases have been reported and they can present with multisystem involvement. Life-threatening complications evolve from deleterious effects on cardiopulmonary and renal systems. Effects on neurological and gastrointestinal systems give rise to a multitude of complications although non-fatal in nature. The biochemical panel consists of a high concentration of ethylene glycol with severe metabolic acidosis, high anion gap, high osmolar gap, oxaluria, and hypocalcemia. The mainstay of treatment is enhanced elimination of ethylene glycol and its metabolites by hemodialysis, together with general supportive care, gastric decontamination, and vitamins such as thiamine and pyridoxine to minimize the adverse effects of intoxication. A 26-year-old Sinhalese woman presented with reduced urine output, shortness of breath, reduced level of consciousness, abdominal pain, and vomiting with mild degree fever of 2 days’ duration. She had bilateral lower limb edema, crepitations over bilateral lower lung fields, and right-sided lower motor type facial nerve palsy. Investigations showed severe metabolic acidosis with high anion gap and high osmolar gap. With regular hemodialysis she made a complete recovery after 3 months. Even without a clear history of poisoning, the presence of a high anion, high osmolar gap metabolic acidosis should prompt one to search for ethylene glycol ingestion. Uncommon manifestations like cranial neuropathies need to be examined and considered. Timely aggressive treatment leads to a better prognosis.
- 3 July 2019
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 13 (1) , 1-4
Open AccessEthylene glycol intoxication following brake fluid ingestion complicated with unilateral facial nerve palsy: a case report
Brake oil is an automobile transmission fluid composed of a mixture of toxic alcohols such as ethylene glycols and glycol ethers. Both accidental and intentional ingestion cases have been reported and they can present with multisystem involvement. Life-threatening complications evolve from deleterious effects on cardiopulmonary and renal systems. Effects on neurological and gastrointestinal systems give rise to a multitude of complications although non-fatal in nature. The biochemical panel consists of a high concentration of ethylene glycol with severe metabolic acidosis, high anion gap, high osmolar gap, oxaluria, and hypocalcemia. The mainstay of treatment is enhanced elimination of ethylene glycol and its metabolites by hemodialysis, together with general supportive care, gastric decontamination, and vitamins such as thiamine and pyridoxine to minimize the adverse effects of intoxication. A 26-year-old Sinhalese woman presented with reduced urine output, shortness of breath, reduced level of consciousness, abdominal pain, and vomiting with mild degree fever of 2 days’ duration. She had bilateral lower limb edema, crepitations over bilateral lower lung fields, and right-sided lower motor type facial nerve palsy. Investigations showed severe metabolic acidosis with high anion gap and high osmolar gap. With regular hemodialysis she made a complete recovery after 3 months. Even without a clear history of poisoning, the presence of a high anion, high osmolar gap metabolic acidosis should prompt one to search for ethylene glycol ingestion. Uncommon manifestations like cranial neuropathies need to be examined and considered. Timely aggressive treatment leads to a better prognosis.
- Open Access
- 4 September 2018
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 11 (1) , 16
A patient with heroin withdrawal presenting with new onset seizures; a case report
- 4 September 2018
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 11 (1) , 16
Open AccessA patient with heroin withdrawal presenting with new onset seizures; a case report
- Open Access
- 1 June 2017
- Vol. 8 (3) , 217-219
Fever of unknown origin in a male patient with systemic lupus erythematosus
In the evaluation of fever of unknown origin, one should be guided by the presenting symptoms and signs of a patient and even though uncommon, SLE is a worthwhile diagnosis to investigate even in a male patient if the clinical picture is suggestive.
- 1 June 2017
- Vol. 8 (3) , 217-219
Open AccessFever of unknown origin in a male patient with systemic lupus erythematosus
In the evaluation of fever of unknown origin, one should be guided by the presenting symptoms and signs of a patient and even though uncommon, SLE is a worthwhile diagnosis to investigate even in a male patient if the clinical picture is suggestive.
- Open Access
- 14 May 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-4
Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report
Castleman disease is a rare lymphoproliferative disorder presenting with localized or disseminated lymphadenopathy and systemic manifestations. It can be categorized in numerous ways, such as unicentric versus multicentric, histopathological variants (hyaline-vascular, plasma cell, and mixed), or subtypes based on causative viral infections (human immunodeficiency virus, human herpesvirus-8, or Kaposi sarcoma herpesvirus). Presentation ranges from asymptomatic to symptoms involving multiple organs. Even though the exact mechanism of pathogenesis is unknown, treatment is directed toward possible etiologies such as interleukin-6, cluster of differentiation 20, and viral agents. A 36-year-old Sri Lankan woman presented with generalized body swelling and foamy urine of 2 weeks’ duration. Examination revealed pallor; generalized edema; axillary, cervical, and inguinal lymphadenopathy; hypertension; and hepatomegaly. Investigations showed bicytopenia, nephrotic range proteinuria with hypoalbuminemia, hypogammaglobulinemia, and features of hyaline-vascular type Castleman disease in a lymph node biopsy. She was managed with rituximab and had good clinical improvement. Castleman disease has a broad spectrum of clinical manifestations, disease pathogeneses, and associations and/or complications. Medical professionals need to be familiar with this spectrum because timely diagnosis and aggressive targeted therapy are the cornerstones of managing these patients.
- 14 May 2017
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-4
Open AccessMulticentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report
Castleman disease is a rare lymphoproliferative disorder presenting with localized or disseminated lymphadenopathy and systemic manifestations. It can be categorized in numerous ways, such as unicentric versus multicentric, histopathological variants (hyaline-vascular, plasma cell, and mixed), or subtypes based on causative viral infections (human immunodeficiency virus, human herpesvirus-8, or Kaposi sarcoma herpesvirus). Presentation ranges from asymptomatic to symptoms involving multiple organs. Even though the exact mechanism of pathogenesis is unknown, treatment is directed toward possible etiologies such as interleukin-6, cluster of differentiation 20, and viral agents. A 36-year-old Sri Lankan woman presented with generalized body swelling and foamy urine of 2 weeks’ duration. Examination revealed pallor; generalized edema; axillary, cervical, and inguinal lymphadenopathy; hypertension; and hepatomegaly. Investigations showed bicytopenia, nephrotic range proteinuria with hypoalbuminemia, hypogammaglobulinemia, and features of hyaline-vascular type Castleman disease in a lymph node biopsy. She was managed with rituximab and had good clinical improvement. Castleman disease has a broad spectrum of clinical manifestations, disease pathogeneses, and associations and/or complications. Medical professionals need to be familiar with this spectrum because timely diagnosis and aggressive targeted therapy are the cornerstones of managing these patients.
- Open Access
- 1 September 2016
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 10 (1) , 17
Spontaneous Pneumothorax in a Patient with Marfanoid Habitus
A 39-year-old smoker with Marfanoid habitus presented with sudden onset shortness of breath. The diagnosis of right-sided primary spontaneous pneumothorax was made. It was successfully managed by drainage with inter costal tube. Presence of Marfanoid phenotype and smoking will increase the risk of spontaneous pneumothorax.
- 1 September 2016
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 10 (1) , 17
Open AccessSpontaneous Pneumothorax in a Patient with Marfanoid Habitus
A 39-year-old smoker with Marfanoid habitus presented with sudden onset shortness of breath. The diagnosis of right-sided primary spontaneous pneumothorax was made. It was successfully managed by drainage with inter costal tube. Presence of Marfanoid phenotype and smoking will increase the risk of spontaneous pneumothorax.
- Open Access
- 15 May 2016
- Published by Journal of Case Reports in Journal of Case Reports
- Vol. 6 (2) , 210-213
Epstein - Barr virus Associated Hemophagocytic Syndrome
Hemophagocytic syndrome is a rare disorder with impaired activity of natural killer cells and cytotoxic T lymphocytes. There is excessive activation of lymphocytes and macrophages, hypercytokinaemia and uncontrolled hemophagocytosis. It is characterized by fever, pancytopenia, splenomegaly and hemophagocytosis in bone marrow and other tissues. The syndrome is associated with collagen vascular diseases, malignancies and infections most frequently caused by viruses, prominently linked with Epstein-Barr viral infection. We report a case of Epstein-Barr virus associated hemophagocytic syndrome in a 19 year old boy who responded to treatment with steroids and etoposide.
- 15 May 2016
- Published by Journal of Case Reports in Journal of Case Reports
- Vol. 6 (2) , 210-213
Open AccessEpstein - Barr virus Associated Hemophagocytic Syndrome
Hemophagocytic syndrome is a rare disorder with impaired activity of natural killer cells and cytotoxic T lymphocytes. There is excessive activation of lymphocytes and macrophages, hypercytokinaemia and uncontrolled hemophagocytosis. It is characterized by fever, pancytopenia, splenomegaly and hemophagocytosis in bone marrow and other tissues. The syndrome is associated with collagen vascular diseases, malignancies and infections most frequently caused by viruses, prominently linked with Epstein-Barr viral infection. We report a case of Epstein-Barr virus associated hemophagocytic syndrome in a 19 year old boy who responded to treatment with steroids and etoposide.
- Open Access
- 26 December 2015
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 9 (2) , 41
A rare presentation of Henoch-Schonlein Purpura with facial involvement in a teenager
Henoch-Schonlein purpura is a small vessel vasculitis characterized by cutaneous, joint, gastrointestinal and renal involvement. Vasculitic purpura is mainly seen on lower limbs & buttocks and rarely on face & upper limbs. We report a 13 year old girl with Henoch Schonlein purpura, who presented with purpuric rash predominantly involving the face, ears and upper limbs.
- 26 December 2015
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 9 (2) , 41
Open AccessA rare presentation of Henoch-Schonlein Purpura with facial involvement in a teenager
Henoch-Schonlein purpura is a small vessel vasculitis characterized by cutaneous, joint, gastrointestinal and renal involvement. Vasculitic purpura is mainly seen on lower limbs & buttocks and rarely on face & upper limbs. We report a 13 year old girl with Henoch Schonlein purpura, who presented with purpuric rash predominantly involving the face, ears and upper limbs.